We are live on ! Find out more
PC

Pavadi Capital Portfolio holdings

AUM $81.2M
1-Year Est. Return 5.26%
This Fund
S&P 500
This Quarter Est. Return
-10.53%
1 Year Est. Return
+5.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$110M
AUM Growth
-$3.18M
Cap. Flow
+$10.8M
Cap. Flow %
9.81%
Top 10 Hldgs %
57.21%
Holding
26
New
1
Increased
21
Reduced
–
Closed
4

Top Buys

Rank Stock Value
1
NVST icon
Envista
NVST
+$3.72M
2
MOH icon
Molina Healthcare
MOH
+$1.41M
3
CNC icon
Centene
CNC
+$1.4M
4
CAH icon
Cardinal Health
CAH
+$1.21M
5
THC icon
Tenet Healthcare
THC
+$1.05M

Top Sells

Rank Stock Value
1
UHS icon
Universal Health Services
UHS
+$4.78M
2
CYH icon
Community Health Systems
CYH
+$3.08M
3
MCK icon
McKesson
MCK
+$1.87M
4
COR icon
Cencora
COR
+$1.02M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNC icon
1
Centene
CNC
$30.7B
$8.98M 8.14%
106,108
+16,894
+19% +$1.4M
MOH icon
2
Molina Healthcare
MOH
$10.2B
$8.21M 7.45%
29,374
+4,673
+19% +$1.41M
CAH icon
3
Cardinal Health
CAH
$53.9B
$7.02M 6.36%
134,227
+21,374
+19% +$1.21M
AMN icon
4
AMN Healthcare
AMN
$1.3B
$6.77M 6.14%
61,700
+9,828
+19% +$973K
DGX icon
5
Quest Diagnostics
DGX
$25.7B
$6.14M 5.56%
46,156
+7,344
+19% +$1M
SYNH
6
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$5.53M 5.01%
77,155
+12,284
+19% +$898K
HOLX
7
DELISTED
Hologic
HOLX
$5.37M 4.86%
77,438
+12,330
+19% +$915K
HUM icon
8
Humana
HUM
$43.7B
$5.11M 4.64%
10,924
+1,738
+19% +$773K
LH icon
9
Labcorp
LH
$25.4B
$5M 4.53%
24,832
+3,956
+19% +$843K
THC icon
10
Tenet Healthcare
THC
$20.5B
$4.99M 4.52%
94,881
+15,111
+19% +$1.05M
CVS icon
11
CVS Health
CVS
$133B
$4.83M 4.38%
52,133
+8,302
+19% +$810K
UNH icon
12
UnitedHealth
UNH
$376B
$4.79M 4.35%
9,335
+1,481
+19% +$744K
MRVI icon
13
Maravai LifeSciences
MRVI
$969M
$4.5M 4.08%
158,520
+25,241
+19% +$800K
CI icon
14
Cigna
CI
$73.8B
$4.48M 4.06%
17,009
+2,698
+19% +$695K
FLGT icon
15
Fulgent Genetics
FLGT
$470M
$4.43M 4.02%
81,277
+12,944
+19% +$711K
ELV icon
16
Elevance Health
ELV
$81.5B
$4.42M 4%
9,149
+1,455
+19% +$720K
XRAY icon
17
Dentsply Sirona
XRAY
$2.68B
$3.7M 3.35%
103,434
+16,468
+19% +$666K
NVST icon
18
Envista
NVST
$4.44B
$3.41M 3.09%
+88,456
New +$3.72M
QDEL icon
19
QuidelOrtho
QDEL
$1.14B
$3.34M 3.03%
34,353
+5,460
+19% +$557K
INMD icon
20
InMode
INMD
$870M
$3.18M 2.88%
141,834
+22,579
+19% +$593K
PHG icon
21
Philips
PHG
$25.7B
$3.1M 2.81%
167,870
+21,559
+15% +$465K
HCA icon
22
HCA Healthcare
HCA
$87.2B
$3.02M 2.74%
17,980
+2,860
+19% +$614K
COR icon
23
Cencora
COR
$60.6B
– –
-6,598
Closed -$1.02M
CYH icon
24
Community Health Systems
CYH
$393M
– –
-259,719
Closed -$3.08M
MCK icon
25
McKesson
MCK
$100B
– –
-6,102
Closed -$1.87M
1
2

Similar funds

BAM
Broadmark Asset Management San Francisco, California $80.4M AUM 29.98% 1-Year Est. Return
TCM
Tegean Capital Management New York $82.1M AUM 12.91% 1-Year Est. Return
JAM
JLP Asset Management New York $84.2M AUM 10.86% 1-Year Est. Return
HH
HP Holding New York $84.5M AUM 4.73% 1-Year Est. Return
CPI
Canaan Partners IX Menlo Park, California $87.5M AUM
SLM
Snow Lake Management Menlo Park, California $90.7M AUM 72.65% 1-Year Est. Return
AFG
Alterity Financial Group Bangor, Maine $69.9M AUM 40.65% 1-Year Est. Return
TIMH
Tilt Investment Management Holdings New York $92.6M AUM 28.92% 1-Year Est. Return

Pavadi Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Pavadi Capital held 26 positions worth $110M, down 2.8% from $113M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Pavadi Capital deployed $10.8M of net new capital in Q2 2022, opening 1 new position and adding to 21 existing holdings. Its largest new stake was Envista: 88,456 shares worth $3.41M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the most notable exit was Universal Health Services, an estimated $4.78M sold.

  • Pavadi Capital's largest Q2 2022 buy was Envista: 88,456 shares worth $3.41M.
  • Pavadi Capital added most to Molina Healthcare in Q2 2022, an estimated $1.41M increase.
  • Pavadi Capital fully exited Universal Health Services in Q2 2022, selling an estimated $4.78M.
  • Pavadi Capital's ten largest holdings make up 57% of its $110M portfolio in Q2 2022.
  • Pavadi Capital opened 1 new position and closed 4 in Q2 2022.
  • Pavadi Capital's portfolio value fell 2.8% quarter-over-quarter to $110M.

Based on Pavadi Capital's 13F filing for Q2 2022, filed 15 Aug 2022.